According to Seoul Economic Daily, Lemon Healthcare listed on South Korea's KOSDAQ on July 6, raising 20 billion won (approximately $15 million USD equivalent) with a projected market valuation of 133.5 billion won. Founded in 2017, the company operates a bidirectional medical data platform providing real-time patient data conversion and transmission services to hospitals.
The IPO attracted robust institutional demand with a 1,238:1 competition ratio among 2,233 institutions and a 1,511:1 subscription ratio from retail investors. Approximately 3.8 trillion won in subscription deposits were collected. KB Securities served as lead underwriter.